ETF Holdings Breakdown of WVE

Stock NameWave Life Sciences Ltd
TickerWVE(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINSG9999014716

News associated with WVE

Hsbc Holdings PLC Sells 3,565 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)
Hsbc Holdings PLC lessened its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 25.0% during the 4th quarter, Holdings Channel reports. The firm owned 10,721 shares of the company’s stock after selling 3,565 shares during the period. Hsbc Holdings PLC’s holdings in Wave Life Sciences were worth $132,000 at the […] - 2025-05-12 07:56:50
Voya Investment Management LLC Acquires 51,281 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)
Voya Investment Management LLC increased its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 198.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 77,160 shares of the company’s stock after buying an additional 51,281 shares during the period. Voya Investment Management LLC’s holdings in Wave Life Sciences were […] - 2025-05-07 08:57:01
MetLife Investment Management LLC Buys 12,340 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)
MetLife Investment Management LLC increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 28.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,941 shares of the company’s stock after buying an additional 12,340 shares […] - 2025-05-05 08:22:48
Barclays PLC Has $2.42 Million Stake in Wave Life Sciences Ltd. (NASDAQ:WVE)
Barclays PLC increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 22.8% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 195,553 shares of the company’s stock after buying an additional 36,312 shares during the quarter. Barclays PLC’s holdings in Wave Life Sciences were worth $2,418,000 at the […] - 2025-05-01 08:12:58
Wave Life Sciences (NASDAQ:WVE) Earns Overweight Rating from Analysts at Cantor Fitzgerald
Research analysts at Cantor Fitzgerald initiated coverage on shares of Wave Life Sciences (NASDAQ:WVE – Get Free Report) in a research note issued on Tuesday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $10.00 price target on the stock. Cantor Fitzgerald’s price objective suggests a potential upside of 29.53% from the company’s […] - 2025-05-01 06:02:55
Russell Investments Group Ltd. Boosts Position in Wave Life Sciences Ltd. (NASDAQ:WVE)
Russell Investments Group Ltd. increased its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 3,471.8% in the 4th quarter, HoldingsChannel reports. The fund owned 44,648 shares of the company’s stock after purchasing an additional 43,398 shares during the quarter. Russell Investments Group Ltd.’s holdings in Wave Life Sciences were worth $552,000 at […] - 2025-04-24 07:44:47
Wave Life Sciences (NASDAQ:WVE) Now Covered by Analysts at Wedbush
Analysts at Wedbush assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The firm set an “outperform” rating and a $18.00 price target on the stock. Wedbush’s price objective would suggest a potential upside of 193.16% from the stock’s previous […] - 2025-04-10 07:13:09
Teacher Retirement System of Texas Grows Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)
Teacher Retirement System of Texas boosted its position in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 57.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 31,473 shares of the company’s stock after acquiring an additional 11,507 shares during the quarter. Teacher Retirement System of Texas’ holdings in Wave Life Sciences were […] - 2025-04-01 07:44:43
Wave Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Recommendation of “Buy” by Brokerages
Shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) have been given a consensus rating of “Buy” by the ten analysts that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy […] - 2025-03-28 06:08:55
Wave Life Sciences (NASDAQ:WVE) vs. Rhythm Pharmaceuticals (NASDAQ:RYTM) Financial Comparison
Wave Life Sciences (NASDAQ:WVE – Get Free Report) and Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, dividends, analyst recommendations, earnings and profitability. Analyst Recommendations This is a breakdown of […] - 2025-03-12 06:11:02
Wave Life Sciences (NASDAQ:WVE) Stock Rating Upgraded by StockNews.com
Wave Life Sciences (NASDAQ:WVE – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other equities research analysts also recently issued reports on WVE. Jefferies Financial Group began coverage on shares of Wave Life Sciences in a research […] - 2025-03-10 06:20:52
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives $22.60 Consensus PT from Brokerages
Shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) have been given an average rating of “Buy” by the ten brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating […] - 2025-03-06 06:45:53
Rhumbline Advisers Has $1.54 Million Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)
Rhumbline Advisers increased its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 16.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 124,840 shares of the company’s stock after purchasing an additional 17,316 shares during the quarter. Rhumbline […] - 2025-03-05 10:18:53
Wave Life Sciences (NASDAQ:WVE) Coverage Initiated at Jefferies Financial Group
Research analysts at Jefferies Financial Group began coverage on shares of Wave Life Sciences (NASDAQ:WVE – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat Ratings reports. The firm set a “buy” rating and a $26.00 price target on the stock. Jefferies Financial Group’s target price would suggest a potential upside […] - 2025-02-27 08:44:56

WVE institutional holdings

The following institutional investment holdings of WVE have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 61,325USD 401,066 0.8%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 74,149USD 484,934 0.8%
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 74,149USD 484,934 0.8%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,730USD 11,314 0.8%
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 81,247USD 531,355 0.8%
Total =292,600 USD 1,913,603
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.